Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
New funding for Centenary's life saving research

New funding for Centenary's life saving research

Loyola presents Scientist of the Year awards

Loyola presents Scientist of the Year awards

Cancer DNA in patient's bloodstream could help deliver personalized treatment for liver cancer

Cancer DNA in patient's bloodstream could help deliver personalized treatment for liver cancer

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

Researchers uncover genes that can suppress HCV infection within the liver

Researchers uncover genes that can suppress HCV infection within the liver

Researchers develop multiplexed screening approach to study cancer development in mice

Researchers develop multiplexed screening approach to study cancer development in mice

Cancer-causing parasitic worm may help patients recover from wounds, say JCU scientists

Cancer-causing parasitic worm may help patients recover from wounds, say JCU scientists

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Can-Fite's CF102 granted Orphan Drug Designation by EMA for treatment of hepatocellular carcinoma

Cattle virus found in human cancer cells

Cattle virus found in human cancer cells

Researchers establish link between bovine leukemia virus and human breast cancer

Researchers establish link between bovine leukemia virus and human breast cancer

Inhibition of FGFR3 receptor could be a new way of treating patients with liver cell cancer

Inhibition of FGFR3 receptor could be a new way of treating patients with liver cell cancer

New DNA analysis may guide personalized management of hepatocellular carcinoma

New DNA analysis may guide personalized management of hepatocellular carcinoma

ICU-related mortality may explain variations in cancer outcomes

ICU-related mortality may explain variations in cancer outcomes

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

World Hepatitis Summit highlights need to develop national programmes that can eliminate viral hepatitis

World Hepatitis Summit highlights need to develop national programmes that can eliminate viral hepatitis

TGen scientists identify potential gene associated with NAFLD-related liver damage

TGen scientists identify potential gene associated with NAFLD-related liver damage

MACC1 gene can help predict better treatment options for patients with Klatskin carcinoma

MACC1 gene can help predict better treatment options for patients with Klatskin carcinoma

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.